about
Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study.Assessment of tissue fibrosis in skin biopsies from patients with systemic sclerosis employing confocal laser scanning microscopy: an objective outcome measure for clinical trials?Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosisEffect of low-dose tacrolimus with mycophenolate mofetil on renal function following liver transplantation.In rat renal fibroblasts, mycophenolic acid inhibits proliferation and production of the chemokine CCL2, stimulated by tumour necrosis factor-alpha.Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients.Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.Effects of mycophenolate mofetil on kidney function and phosphorylation status of renal proteins in Alport COL4A3-deficient miceMycophenolic acid inhibits migration and invasion of gastric cancer cells via multiple molecular pathways.Influence of mTOR-inhibitors and mycophenolic acid on human cholangiocellular carcinoma and cancer associated fibroblastsPrevention of hepatitis C recurrence after liver transplantation: An update.Medical management of retroperitoneal fibrosis.Mycophenolate mofetil in the treatment of lupus nephritis.Hepatic inflammation and progressive liver fibrosis in chronic liver disease.Advances in the current treatment of autoimmune hepatitis.Drug choices in autoimmune hepatitis: part B--Nonsteroids.Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis.Current and prospective pharmacotherapy for autoimmune hepatitis.Evolving paradigm of treatment for autoimmune hepatitis.Transcriptomic changes induced by mycophenolic acid in gastric cancer cells.Delineation of biological and molecular mechanisms underlying the diverse anticancer activities of mycophenolic acid.Long-Term Impact of Cyclosporin Reduction with MMF Treatment in Chronic Allograft Dysfunction: REFERENECE Study 3-Year Follow UpEffect of mycophenolic acid on cyclosporin A-induced fibronectin expression in rat mesangial cells.Mycophenolate mofetil: a novel immunosuppressant in the treatment of dystrophic epidermolysis bullosa, a randomized controlled trial.Outcome of severe steroid-dependent nephrotic syndrome treated with mycophenolate mofetil.Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.Mycophenolic Acid-Induced Developmental Defects in Zebrafish Embryos.Oxidative Stress and Renal Fibrosis: Recent Insights for the Development of Novel Therapeutic Strategies.Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C
P2860
Q33394798-29E3CCFF-AB11-4B99-AB13-949F9E2FC836Q33536943-B201E5E6-1251-4C1E-85BA-BC4FB206CF8FQ33602730-F9D597A7-27E2-41AA-97BC-0A0F5AD1CB75Q34093890-2264B306-2B01-46A1-9995-551A6C1B579EQ34116774-2F15AAA6-7E2E-4E13-833E-62A707C2E5B0Q34168552-E1CA71D7-5DB8-42E0-9EE6-5715D553838FQ34409787-F3FEA7BB-92D4-4E54-A2BB-75FF60FF2F39Q34728886-BBE84B5A-EC5C-4CCD-B597-A79921A2C3D7Q35049578-E8EEB8B1-DDE3-470A-9044-77B0415C6367Q36024387-C8BB406E-9849-4E33-B344-A9B7F1DDB007Q36220172-DC19EFD6-0AB2-4837-8E7A-B97C479FED62Q36519714-B3C1E04D-0A3A-490E-B4D2-2FAF2F23F464Q37290624-C6ED05DB-0C7B-4260-9ADF-469EFEAB008CQ37629675-052F56D4-72A7-49F0-9339-F80CEF30AE41Q38000056-F4B232C8-1244-46DF-B439-30A0901417A7Q38051706-7692E2AB-78AD-4EE4-BC2E-6291DB63AB10Q38175465-8ABED772-179B-438A-B2AD-5E046702BE4CQ38222882-8C5747A2-459F-49D5-8349-19683FF34999Q38730872-3C91F874-5208-4EBD-B046-B8CFDA68AB0EQ39042222-25B14F22-7778-4F5B-91D5-1F8A541CA79EQ39051365-AE57EB35-448C-4C18-81A9-E1808FFB2B10Q42612170-0079DF5E-6883-45A4-87BE-407E034A8615Q43693945-3B67BE05-D5DE-4D5C-A328-070D64D816FDQ46540016-6EF67A94-1F3D-4632-B27B-14F566E90A73Q47267138-388FD177-A3B0-4A36-A760-5702CF12CA22Q47890306-EEECD148-986B-43B3-BBB1-E405C6F95567Q50485528-142E0259-A8F6-44DB-857B-BADC1E971C1CQ52674866-59F599AE-A4E9-442B-AC36-2987B0BD53B1Q57791759-EA63AA8A-7446-41D1-BD6F-088126CDBF73
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Antifibrotic actions of mycophenolic acid.
@ast
Antifibrotic actions of mycophenolic acid.
@en
type
label
Antifibrotic actions of mycophenolic acid.
@ast
Antifibrotic actions of mycophenolic acid.
@en
prefLabel
Antifibrotic actions of mycophenolic acid.
@ast
Antifibrotic actions of mycophenolic acid.
@en
P2093
P2860
P1476
Antifibrotic actions of mycophenolic acid.
@en
P2093
Christian Morath
Jan Schmidt
Jörg Beimler
Martin Zeier
Vedat Schwenger
Walter Muranyi
P2860
P356
10.1111/J.1399-0012.2006.00597.X
P478
20 Suppl 17
P577
2006-01-01T00:00:00Z